University of Pittsburgh
Pittsburgh, Pennsylvania, 15260, United States
NCT Number: NCT02091648
The purpose of the proposed study is to conduct a randomized controlled pilot trial of a school-based stress management and coping skills training program among a sample of economically disadvantaged urban 8- to 12-year-old school children with physician-confirmed asthma. The investigators aim (1) to establish feasibility of this approach by recruiting from different schools and (2) to learn whether individuals assigned to receive the intervention show improvements in psychological function, decreases in lung inflammation, and related improvements in asthma health when compared with disease severity-matched peers who receive education-only or standard care.
Looking for future studies?
Notify Me8 year–14 year
All sexes
Interventional
Not applicable
Pittsburgh, Pennsylvania, 15260, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants randomized to the "I Can Cope" condition will receive 6 face-to-face individualized sessions over a 2-month period. Each session will last 50 minutes and take place at the child's school either during approved times during the school day or as part of the after-school program. Sessions are psychoeducational and experiential and include opportunities for the child with asthma to: (1) learn about the pathophysiology of asthma; (2) understand the biological impact of stress on the body; (3) learn the relationship among thoughts, feelings, actions, and asthma; (4) acquire a set of coping skills to help deal with asthma-related and day-to-day stressors in their lives, and (5) receive training in biofeedback-assisted relaxation techniques.
This group will receive the standard American Lung Association (ALA)"Open Airways for Schools" program. This program includes six 40-minute sessions covering the National Heart Lung and Blood Institute's recommendations for asthma education.
Other names: Open Airways for Schools Program
Time frame: End of enrollment: estimated 2 years after beginning active enrollment.
A measure of the feasibility of offering the "I Can Cope" intervention trial to socioeconomically disadvantaged 8-14 year-old children with physician-confirmed asthma in urban schools.
Time frame: After final outcome measures are collected: up to 2 1/2 years from beginning of active enrollment.
A measure of the feasibility of offering the "I Can Cope" intervention trial to socioeconomically disadvantaged 8-14 year-old children with physician-confirmed asthma in urban schools.
Time frame: After final participant has completed study: estimated 2 1/2 years after beginning active enrollement.
A measure of the feasibility of offering the "I Can Cope" intervention trial to socioeconomically disadvantaged 8-14 year-old children with physician-confirmed asthma in urban schools.
Time frame: End of Study Participation: up to 5 months from initial enrollment.
Time frame: End of enrollment: estimated 2 years after beginning active enrollment.
Time frame: Pre and Post Intervention: baseline, up to 4 months later.
Assess change in symptoms of depression.
Time frame: Pre and Post Intervention: baseline, up to 4 months later.
Assess change in symptoms of anxiety and depression.
Time frame: Pre and post intervention: baseline, up to 4 months later.
Assess change in the degree to which the child perceives current demands as stressful and exceeding his or her ability to cope.
Time frame: Pre and Post Intervention: baseline, up to 4 months later.
Assesses asthma-related quality of life.
Time frame: Pre and Post Intervention: baseline, up to 4 months later.
Parent and child participants will complete the which assesses beliefs that they can perform behaviors to alleviate the child's asthma, including behaviors associated with symptom prevention (e.g., getting to doctor, using medication, and avoiding allergens) as well as symptom management (e.g., staying calm, controlling symptoms, deciding how to manage symptoms).
Time frame: Pre and Post Intervention: baseline, up to 4 months later.
Child participants will complete the Kidcope a 10-item measure of different coping strategies.
Time frame: Pre and Post Intervention: baseline, up to 4 months later.
In order to measure the effectiveness of stress management training, child participants will complete an adapted version of the 10-item Measure of Current Status assessing perceived self-efficacy for skills targeted by the intervention: the ability to relax, to recognize stress-inducing situations, to be assertive about needs, and to choose appropriate coping responses.
Time frame: Pre to post-intervention: baseline, up to 4 months later.
The magnitude of intervention-related improvements in the child's asthma health will be measured by change in pulmonary function, exhaled levels of nitric oxide, and symptoms of asthma, as well as number of medical visits, and school absenteeism.
Time frame: Baseline
Assesses life events that have had a negative impact on the child's psychological state.
University of Pittsburgh
Other
A Pilot Stress Management Intervention for High Risk Children With Asthma
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07394127
Asthma, Asthma Chronic
Gümüşhane, Trabzon, Ordu, Giresun, Rize, Artvin, Gümüşhane, Turkey (Türkiye)
View Trial DetailsNCT01678222
Allergic Inflammation, Asthma
Research Triangle Park, North Carolina, United States
View Trial DetailsNCT03937804
Asthma, Bronchial Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT03927820
Asthma, Bronchial Diseases
Nashville, Tennessee, United States
View Trial Details